Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Cancers
|
December 10, 2021
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
Giulia Bega, Jacopo Olivieri, Marcello Riva, et al.
British Journal of Haematology
|
October 15, 2020
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study
Gessica Marchesini, Gianpaolo Nadali, Davide Facchinelli, et al.
Leukemia Research
|
December 12, 2018
Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience
Carla Filì, Anna Candoni, Maria Elena Zannier, et al.
European Journal of Haematology
|
June 17, 2020
Primary pancreatic lymphoma: Clinical presentation, diagnosis, treatment, and outcome
Davide Facchinelli, Sokol Sina, Enrico Boninsegna, et al.
Journal of Fungi (Basel, Switzerland)
|
June 23, 2022
High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study
Chiara Cattaneo, Francesco Marchesi, Irene Terrenato, et al.
Cancers
|
May 27, 2026
Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) Project
Elisabetta Abruzzese, Monica Crugnola, Luca Garuffo, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Cancers
|
December 10, 2021
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
Giulia Bega, Jacopo Olivieri, Marcello Riva, et al.
British Journal of Haematology
|
October 15, 2020
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study
Gessica Marchesini, Gianpaolo Nadali, Davide Facchinelli, et al.
Leukemia Research
|
December 12, 2018
Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience
Carla Filì, Anna Candoni, Maria Elena Zannier, et al.
European Journal of Haematology
|
June 17, 2020
Primary pancreatic lymphoma: Clinical presentation, diagnosis, treatment, and outcome
Davide Facchinelli, Sokol Sina, Enrico Boninsegna, et al.
Journal of Fungi (Basel, Switzerland)
|
June 23, 2022
High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study
Chiara Cattaneo, Francesco Marchesi, Irene Terrenato, et al.
Cancers
|
May 27, 2026
Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) Project
Elisabetta Abruzzese, Monica Crugnola, Luca Garuffo, et al.
Page
of 2